Watchlist Price Alert

Bellerophon Therapeutics ... (BLPH)

NASDAQ: BLPH · Real-Time Price · USD

0.01

-0.01 (-47.37%)

At close: Dec 18, 2024, 5:51 PM

Bellerophon Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-19.83M	-17.76M	-24.73M	-13.27M	2.81M	-54.82M	-23.81M
Depreciation & Amortization	65K	102K	147K	348K	362K	373K	400K
Stock-Based Compensation	786K	1.13M	1.63M	2.15M	2.96M	2.84M	2.76M
Other Working Capital	386K	-200K	-15K	245K	2.76M	4.57M	4.31M
Other Non-Cash Items	-1K	-600K	300K	-2.01M	-22.06M	30.51M	1M
Deferred Income Tax	n/a	n/a	327K	n/a	-2.81M	-6K	34K
Change in Working Capital	1.21M	-5.69M	2.44M	-161K	3.25M	5.36M	2.4M
Operating Cash Flow	-17.77M	-22.82M	-19.88M	-12.94M	-15.49M	-15.74M	-17.21M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	-22K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-5.98M	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	3M	8.56M	12.22M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	3M	2.58M	12.2M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-28K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-40K	n/a	2.87M	-69K	194K	2.53M	-128K
Financial Cash Flow	-40K	n/a	57.57M	6.17M	166K	27.78M	13.21M
Net Cash Flow	-17.81M	-22.82M	37.68M	-6.77M	-12.33M	14.62M	8.19M
Free Cash Flow	-17.77M	-22.82M	-19.88M	-12.94M	-15.49M	-15.74M	-17.23M